Abstract

Phage display is considered as a gold-standard technique for the extraction of monoclonal antibodies. Within the past decade, the technique has been extensively applied in clinical studies for the discovery of peptides, ligands and antibodies that can be implemented for the detection of clinical biomarkers and therapeutic purposes. This review highlights recent advancements in the field of phage display technology that has aided medicine in therapeutic and diagnostic terms.